LayerP Technology

Secure Your Corporate Connection to and from LLMs with LayerP

Data Security Risk

According to The Gartner Market Guide for Artificial Intelligence Trust, Risk and Security Management (AI TRiSM), “two in five organizations had an AI privacy breach or security incident,”, which highlights the importance of applying privacy controls to data that is used for interacting with AI models. And you don't want your organization to become a part of this "two".

Problem

Many companies and organizations are keen to explore or have already started utilizing Large Language Models (LLMs) to improve business operations, increase efficiency, and enhance employee productivity, as well as for scientific research. However, they also have concerns about the potential risk of employees unintentionally revealing confidential or sensitive information during these processes. Additionally, while a custom language model may be trained on proprietary data, it’s important to ensure that the model’s output does not contain sensitive information, especially if vendors or suppliers or other external entities have access to it.

Solution

What is LayerP

LayerP technology provides a shield that protects organizations' sensitive information and intellectual property from inadvertently leaking to or from Large Language Models (LLMs).

Imagine a security layer positioned between corporate users and an LLM that automatically detects whether an outgoing prompt or response from the model contains confidential or sensitive information. When it does, the layer alerts the user of such a case and stops the prompt from reaching the LLM or the response from reaching the user. This approach effectively prevents accidental leakage of sensitive information. Because it's a thin layer, it introduces minimal delay—taking less than one second—ensuring a seamless user experience with low latency.

LayerP Diagram

Sample sensitive data/questions/prompts:

"As a senior researcher at BioThera, I've helped develop our novel gene therapy vector, 'Genex'. This vector delivers therapeutic genes directly into specific cells, enhancing efficacy and reducing off-target effects. Considering its potential to treat genetic disorders effectively, should we present this to potential strategic partners for collaboration?"

"Following our successful internal tests, the new formulation technique for our leading drug, which is currently generating $500 million in annual revenue, is projected to save us $50 million annually. This change is also expected to extend the drug's patent life by five years past the original expiration in 2025, thwarting generic competition. Considering these figures, what should we expect regarding our stock price and strategic positioning in the market against competitors like BioCentury21 and NewGenBlueSky LLC who are developing similar therapies?"

Who We Are

LayerP Technology, LLC, based in Greenville, South Carolina, was founded by technologist Don Chunshen Li.